Teleflex Inc (TFX)
192.15
+1.37
(+0.72%)
USD |
NYSE |
Nov 15, 16:00
192.24
+0.09
(+0.05%)
After-Hours: 20:00
Teleflex Research and Development Expense (TTM): 152.98M for Sept. 30, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
Date | Value |
---|---|
September 30, 2024 | 152.98M |
June 30, 2024 | 151.83M |
March 31, 2024 | 150.18M |
December 31, 2023 | 154.35M |
September 30, 2023 | 161.25M |
June 30, 2023 | 161.44M |
March 31, 2023 | 158.93M |
December 31, 2022 | 153.82M |
September 30, 2022 | 146.86M |
June 30, 2022 | 140.90M |
March 31, 2022 | 137.25M |
December 31, 2021 | 130.84M |
September 30, 2021 | 128.82M |
June 30, 2021 | 126.22M |
March 31, 2021 | 122.30M |
December 31, 2020 | 119.75M |
September 30, 2020 | 117.11M |
June 30, 2020 | 115.87M |
March 31, 2020 | 114.10M |
December 31, 2019 | 113.86M |
September 30, 2019 | 110.53M |
June 30, 2019 | 108.91M |
March 31, 2019 | 107.33M |
December 31, 2018 | 106.21M |
September 30, 2018 | 103.88M |
Date | Value |
---|---|
June 30, 2018 | 98.71M |
March 31, 2018 | 92.97M |
December 31, 2017 | 84.77M |
September 30, 2017 | 74.99M |
June 30, 2017 | 68.86M |
March 31, 2017 | 64.05M |
December 31, 2016 | 58.58M |
September 30, 2016 | 56.11M |
June 30, 2016 | 53.62M |
March 31, 2016 | 51.59M |
December 31, 2015 | 52.12M |
September 30, 2015 | 56.14M |
June 30, 2015 | 58.44M |
March 31, 2015 | 59.86M |
December 31, 2014 | 61.04M |
September 30, 2014 | 61.68M |
June 30, 2014 | 62.45M |
March 31, 2014 | 64.10M |
December 31, 2013 | 65.04M |
September 30, 2013 | 63.43M |
June 30, 2013 | 62.55M |
March 31, 2013 | 59.73M |
December 31, 2012 | 56.28M |
September 30, 2012 | 52.92M |
June 30, 2012 | 50.48M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
113.86M
Minimum
Dec 2019
161.44M
Maximum
Jun 2023
137.93M
Average
139.08M
Median
Research and Development Expense (TTM) Benchmarks
Boston Scientific Corp | 1.519B |
Globus Medical Inc | 182.60M |
Edwards Lifesciences Corp | 1.162B |
Insulet Corp | 201.00M |
PROCEPT BioRobotics Corp | 61.73M |